CARTHERA – Trademark Portfolio

Entity Type: 09

CARTHERA holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SONOCLOUD. The owner is based in PARIS Cedex 13.

47-83 boulevard de l'Hôpital

Hôpital Pitié Salpêtrière Bât. Babinski

PARIS Cedex 13 75651 , FR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CARTHERA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does CARTHERA have?

CARTHERA has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does CARTHERA file in?

CARTHERA files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CARTHERA's most well-known trademarks?

CARTHERA's registered trademark portfolio includes well-known marks such as SONOCLOUD. These are among 1 currently registered trademark in the portfolio.

What is CARTHERA's trademark registration success rate?

CARTHERA has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.